• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物血凝素刺激后人淋巴细胞中拓扑异构酶II基因表达的诱导。

Induction of topoisomerase II gene expression in human lymphocytes upon phytohemagglutinin stimulation.

作者信息

Hwong C L, Wang C H, Chen Y J, Whang-Peng J, Hwang J L

机构信息

Institute of Molecular Biology, Academia Sinica, Taipei, Republic of China.

出版信息

Cancer Res. 1990 Sep 1;50(17 Suppl):5649S-5652S.

PMID:2167162
Abstract

The carboxyl-terminal one-third of human topoisomerase II polypeptide expressed in Escherichia coli was used as antigen to generate polyclonal antibodies in rabbits. With the use of antiserum, DNA topoisomerase II levels of phytohemagglutinin-stimulated human lymphocytes were measured by immunoblotting. Our results showed that the increase in intracellular topoisomerase II level paralleled the entry of cells into proliferation. We also found that the increase in the topoisomerase II level resulted from an increase in the amount of topoisomerase II mRNA. The time course study indicated that the appearance of topoisomerase II mRNA was first observed at 36 h after phytohemagglutinin stimulation. The maximal level of topoisomerase II mRNA was seen at 45 h after stimulation. The same RNA blot was rehybridized with a thymidine kinase probe. The maximal level of thymidine kinase mRNA was observed at 39 h after phytohemagglutinin stimulation. In a comparison of the time course of topoisomerase II gene expression with that of [3H]thymidine incorporation and thymidine kinase gene expression, it was found that the expression of the topoisomerase II gene was later than the onset of DNA replication. Thus, this study suggests that topoisomerase I, which is constantly expressed throughout the cell cycle, might participate in the initiation of DNA replication, while topoisomerase II is involved in solving the DNA topological problems accompanying DNA strand separation during DNA replication.

摘要

以在大肠杆菌中表达的人拓扑异构酶II多肽的羧基末端三分之一作为抗原,在兔体内产生多克隆抗体。利用抗血清,通过免疫印迹法检测植物血凝素刺激的人淋巴细胞的DNA拓扑异构酶II水平。我们的结果表明,细胞内拓扑异构酶II水平的增加与细胞进入增殖阶段平行。我们还发现,拓扑异构酶II水平的增加是由于拓扑异构酶II mRNA量的增加所致。时间进程研究表明,在植物血凝素刺激后36小时首次观察到拓扑异构酶II mRNA的出现。刺激后45小时观察到拓扑异构酶II mRNA的最大水平。用胸苷激酶探针将同一RNA印迹重新杂交。在植物血凝素刺激后39小时观察到胸苷激酶mRNA的最大水平。在比较拓扑异构酶II基因表达的时间进程与[3H]胸苷掺入和胸苷激酶基因表达的时间进程时,发现拓扑异构酶II基因的表达晚于DNA复制的起始。因此,本研究表明,在整个细胞周期中持续表达的拓扑异构酶I可能参与DNA复制的起始,而拓扑异构酶II则参与解决DNA复制过程中伴随DNA链分离的DNA拓扑问题。

相似文献

1
Induction of topoisomerase II gene expression in human lymphocytes upon phytohemagglutinin stimulation.植物血凝素刺激后人淋巴细胞中拓扑异构酶II基因表达的诱导。
Cancer Res. 1990 Sep 1;50(17 Suppl):5649S-5652S.
2
Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide.
Cancer Res. 1989 Feb 15;49(4):958-62.
3
DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.依托泊苷/替尼泊苷耐药的人癌细胞中受转录调控的DNA拓扑异构酶IIα基因表达
Cancer Res. 1995 Sep 1;55(17):3860-4.
4
Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.喜树碱诱导的DNA损伤后,两种p53突变型人结肠癌细胞系中GADD45、p21CIP1/WAF1、MCL-1和拓扑异构酶II基因的差异诱导及继发性DNA片段化
Oncol Res. 1996;8(7-8):317-23.
5
Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.使用聚合酶链反应辅助转录物滴定分析法对小细胞肺癌细胞系及两个耐药亚系中的DNA拓扑异构酶IIα信使核糖核酸水平进行定量分析。
Lab Invest. 1994 Jul;71(1):61-6.
6
Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells.
Cancer Res. 1988 Jun 1;48(11):3230-5.
7
Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.在一种对米托蒽醌耐药的HL-60人白血病细胞系中,拓扑异构酶IIα基因、信使核糖核酸和亚细胞蛋白质分布的改变以及DNA拓扑异构酶IIβ酶表达的降低。
Cancer Res. 1995 Apr 15;55(8):1707-16.
8
Evidence for the participation of topoisomerases I and II in cadmium-induced metallothionein expression in Chinese hamster ovary cells.拓扑异构酶I和II参与镉诱导中国仓鼠卵巢细胞金属硫蛋白表达的证据。
Anticancer Drug Des. 1989 Aug;4(2):107-24.
9
Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.E2F-1/DP-1转录因子复合物过表达后拓扑异构酶I和II抗癌药物的差异细胞毒性途径
Clin Cancer Res. 2000 Apr;6(4):1488-97.
10
Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.佛波酯对HL-60人白血病细胞中拓扑异构酶II活性及基因表达的影响,这些细胞对单核细胞样分化具有不同倾向。
Cancer Res. 1990 Nov 15;50(22):7116-22.

引用本文的文献

1
DNA topoisomerase I and II in cancer chemotherapy: update and perspectives.癌症化疗中的DNA拓扑异构酶I和II:最新进展与展望
Cancer Chemother Pharmacol. 1993;32(2):103-8. doi: 10.1007/BF00685611.
2
Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.Mdr1/P-糖蛋白、拓扑异构酶和谷胱甘肽-S-转移酶π基因在成人及儿童白血病初发和复发状态下的表达
Br J Cancer. 1992 Sep;66(3):507-17. doi: 10.1038/bjc.1992.304.